Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1689
+0.00365 (2.21%)
At close: Sep 11, 2026
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $288.08 million as of September 11, 2026. Its market cap has decreased by -24.62% in one year.
Market Cap
288.08M
Enterprise Value
354.33M
Revenue
2.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
ChartMarket Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 288.08M, an increase of 2,699.83%. That is a compound annual growth rate of 14.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 288.08M | -19.62% |
| Dec 31, 2025 | 358.39M | -1.53% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 815.84M |
| CytoDyn | 276.11M |
| Glorywin Entertainment Group | 234.77M |
| Vaxart | 118.60M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 80.25M |
| Sangamo Therapeutics | 64.21M |
| Nuo Therapeutics | 59.57M |